Update on the Pharmacologic Management of Overactive Bladder: The Present and the Future

Pamela Ellsworth; Eileen Kirshenbaum


Urol Nurs. 2010;30(1):29-39. 

In This Article


Antimuscarinic agents are the current gold standard for pharmacologic treatment of OAB. Over the past few years, there has been a significant increase in the number of antimuscarinic agents available for treating OAB. All of these agents are effective in improving OAB symptoms, with the maximum benefit derived when combined with behavioral therapy (Burgio et al., 2000). Although similar, differences in these agents may allow one to identify unique agents in select patient populations. Further understanding of the pathophysiology of OAB has prompted the investigation of several pharmacologic agents that target different pathways involved in OAB, which may ultimately provide alternative or combination treatment options.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: